Azafaros B.V. Clinical Trial Pipeline: 5 Active Trials, 8 Changes This Month

5

Active Trials

3

Recruiting

3

Phase 3

8

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-07-25	NCT07082543 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in…	overall status: Recruiting → Active, Not Recruiting
2026-07-25	NCT07082543 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in…	Trial sites reduced: 36 -> 26 locations
2026-07-21	NCT07082543 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in…	date change Primary completion pushed: 2027-11-04 -> 2028-02-06
2026-07-21	NCT07082543 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in…	date change Completion pushed: 2027-11-04 -> 2028-03-06
2026-07-21	NCT07082725 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in…	date change Primary completion pushed: 2027-11-04 -> 2028-05-14
2026-07-21	NCT07082725 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in…	date change Completion pushed: 2027-11-04 -> 2028-06-14
2026-07-21	NCT07054515 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in…	date change Primary completion pushed: 2027-11-04 -> 2028-05-14
2026-07-21	NCT07054515 A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in…	date change Completion pushed: 2027-11-04 -> 2028-06-14

New Trial Filings, Last 30 Days

First Posted	Trial	Phase	Status
2026-07-20	NCT07715084 Study to Evaluate the Efficacy and Safety of Nizubaglustat (AZ-3102) in Patients With…	Phase 2	Not Yet Recruiting

Active Trials by Phase

Phase 3

3

Phase 2

2

Active Trials

NCT ID	Title	Condition	Status
Phase 3
NCT07082725	A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in…	Niemann-Pick Type C Disease	Recruiting
NCT07054515	A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in…	Niemann-Pick Type C Disease	Recruiting
NCT07082543	A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in…	Gangliosidoses, GM2	Active, Not Recruiting
Phase 2
NCT07399704	A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With…	GM2 Gangliosidosis	Recruiting
NCT07715084	Study to Evaluate the Efficacy and Safety of Nizubaglustat (AZ-3102) in Patients With…	Gaucher Disease Type 3	Not Yet Recruiting

Get alerts when Azafaros B.V.'s trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.